# US 2022/0031788 A1 · Anti-Inflammatory Botanical Extract

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0031788 A1
- Document ID: US20220031788A1
- Status: Published application
- Kind: A1
- Application number: 17/467,830
- Filed: 2021-09-07
- Published: 2022-02-03
- Earliest claimed: 2018-09-07
- Assignees: Innophos, Inc.
- Applicants: Innophos, LLC
- Inventors: Jatinder Rana; Kylie Mitchell
- Web page: https://patentgrep.com/patent/US20220031788A1

## CPC

- A61K 36/45: Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- A61K 31/353: 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A botanical extract that exhibits anti-inflammatory activity, wherein the botanical extract is at least an extract from the leaf of Vaccinium macrocarpon.

## Claims

### Claim 1

A composition comprising:
the botanical extract of the leaf of Vaccinium macrocarpon,
wherein the botanical extract is present in the composition in an amount of about 50.0 μg/mL to about 500.0 μg/mL,
wherein the botanical extract is free of anthocyanins, and
wherein the botanical extract has a flavonoid content of at least about twenty times greater than that of an extract of the fruit of Vaccinium macrocarpon,
wherein the composition exhibits anti-inflammatory activity.

### Claim 2 (depends on 1)

The composition according to claim 1, wherein the composition inhibits COX-1 activity.

### Claim 3 (depends on 1)

The composition according to claim 1, wherein the composition inhibits COX-2 activity.

### Claim 4 (depends on 1)

The composition according to claim 1, wherein the composition inhibits 5-LOX activity.

### Claim 5 (depends on 1)

The composition according to claim 1, wherein the composition inhibits COX-1 activity, COX-2 activity, and 5-LOX activity.

### Claim 6 (depends on 1)

The composition according to claim 1 further comprising a pharmaceutically acceptable carrier.

### Claim 7 (depends on 1)

The composition according to claim 1 wherein the composition is a dietary supplement.

### Claim 8 (depends on 1)

The composition according to claim 1 wherein the composition is a topical composition.
